Zika Virus NS2A and NS4A Downregulate the Promoter Activity of Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells.
This study could help understand the mechanisms how ZIKV controls innate immune responses and may be provided for development of ZIKV-specific medicines.
PMID: 33203823 [PubMed - as supplied by publisher]
Source: Journal of Microbiology and Biotechnology - Category: Biotechnology Authors: Lee JY, Nguyen TTN, Myoung J Tags: J Microbiol Biotechnol Source Type: research
More News: Biotechnology | Brazil Health | France Health | Genetics | Guillain-Barr Syndrome | Microbiology | Outbreaks | Study | Uganda Health | Zika Virus